OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice
Katharina Bürger, Finn Jung, Anja Baumann, et al.
Redox Biology (2023) Vol. 66, pp. 102870-102870
Open Access | Times Cited: 13
Katharina Bürger, Finn Jung, Anja Baumann, et al.
Redox Biology (2023) Vol. 66, pp. 102870-102870
Open Access | Times Cited: 13
Showing 13 citing articles:
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Haixiang Zheng, Leonardo A. Sechi, Eliano Pio Navarese, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Haixiang Zheng, Leonardo A. Sechi, Eliano Pio Navarese, et al.
Cardiovascular Diabetology (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Associations of the Intake of Individual and Multiple Flavonoids with Metabolic Dysfunction Associated Steatotic Liver Disease in the United States
Chen Wang, Meng-Chu Li, Jiali Zhang, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 205-205
Open Access
Chen Wang, Meng-Chu Li, Jiali Zhang, et al.
Nutrients (2025) Vol. 17, Iss. 2, pp. 205-205
Open Access
Metabolic dysfunction-associated steatotic liver disease and increased risk of atrial fibrillation in the elderly: A longitudinal cohort study
Yehua Tang, Jianling Fan, Xingyun Hou, et al.
IJC Heart & Vasculature (2025) Vol. 58, pp. 101676-101676
Closed Access
Yehua Tang, Jianling Fan, Xingyun Hou, et al.
IJC Heart & Vasculature (2025) Vol. 58, pp. 101676-101676
Closed Access
Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Cardiovascular Structure, Function, and the Risk of Heart Failure
Bhavik Bansal, Fanny Lajeunesse-Trempe, Neil Keshvani, et al.
Canadian Journal of Cardiology (2025)
Closed Access
Bhavik Bansal, Fanny Lajeunesse-Trempe, Neil Keshvani, et al.
Canadian Journal of Cardiology (2025)
Closed Access
Targeting Metabolism: Innovative Therapies for MASLD Unveiled
Weixin Wang, Xin Gao, Wei Niu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4077-4077
Open Access
Weixin Wang, Xin Gao, Wei Niu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 4077-4077
Open Access
MASLD is related to impaired alcohol dehydrogenase (ADH) activity and elevated blood ethanol levels: Role of TNFα and JNK
Katharina Bürger, Finn Jung, Katharina Staufer, et al.
Redox Biology (2024) Vol. 71, pp. 103121-103121
Open Access | Times Cited: 3
Katharina Bürger, Finn Jung, Katharina Staufer, et al.
Redox Biology (2024) Vol. 71, pp. 103121-103121
Open Access | Times Cited: 3
Fructose induces hepatic steatosis in adolescent mice linked to the disorders of lipid metabolism, bile acid metabolism, and autophagy
Siwei Deng, Yao Ge, Zhian Zhai, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 129, pp. 109635-109635
Closed Access | Times Cited: 2
Siwei Deng, Yao Ge, Zhian Zhai, et al.
The Journal of Nutritional Biochemistry (2024) Vol. 129, pp. 109635-109635
Closed Access | Times Cited: 2
MASLD does not affect fertility and senolytics fail to prevent MASLD progression in male mice
Jéssica D. Hense, Driele N. Garcia, Bianka M. Zanini, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Jéssica D. Hense, Driele N. Garcia, Bianka M. Zanini, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets
Shengying Qian, Xiaolin Wang, Yingfen Chen, et al.
Seminars in Liver Disease (2024)
Closed Access | Times Cited: 2
Shengying Qian, Xiaolin Wang, Yingfen Chen, et al.
Seminars in Liver Disease (2024)
Closed Access | Times Cited: 2
A weekly 4‐methylpyrazole treatment attenuates the development of non‐obese metabolic dysfunction‐associated steatotic liver disease (MASLD ) in male mice: Role of JNK
Katharina Burger, Finn Jung, Raphaela Staltner, et al.
European Journal of Clinical Investigation (2024)
Open Access
Katharina Burger, Finn Jung, Raphaela Staltner, et al.
European Journal of Clinical Investigation (2024)
Open Access
Antioxidant and Anti-Inflammatory Effects of Opuntia Extracts on a Model of Diet-Induced Steatosis
Irene Besné-Eseverri, María Ángeles Martin, M. Lobo, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1416-1416
Open Access
Irene Besné-Eseverri, María Ángeles Martin, M. Lobo, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1416-1416
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease in Chronic Hepatitis C Virus Infection: From Basics to Clinical and Nutritional Management
Karina González-Aldaco, Luis A. Torres-Reyes, Claudia Ojeda‐Granados, et al.
Clinics and Practice (2024) Vol. 14, Iss. 6, pp. 2542-2558
Open Access
Karina González-Aldaco, Luis A. Torres-Reyes, Claudia Ojeda‐Granados, et al.
Clinics and Practice (2024) Vol. 14, Iss. 6, pp. 2542-2558
Open Access
Limited preventive effects of empagliflozin against metabolic dysfunction-associated steatotic liver disease in a mouse model of fast food diet
Evangelia Makri, Konstantinos Xanthopoulos, Spyros Pettas, et al.
HORMONES (2024)
Closed Access
Evangelia Makri, Konstantinos Xanthopoulos, Spyros Pettas, et al.
HORMONES (2024)
Closed Access
